http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105814072-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 |
filingDate | 2014-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105814072-B |
titleOfInvention | A kind of pentacyclic triterpene structure modified compound and its preparation method and application |
abstract | The present invention relates to a kind of pentacyclic triterpene structure modified compounds and its preparation method and application, and the compound of the present invention can effectively treat psoriasis.Also, the compound of the present invention energy selective depression T H 1 and T H The vitro differentiation of 17 cells, so as to be applied to treat T H 1 and T H 17 autoimmune diseases mediated. |
priorityDate | 2013-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 262.